Stollery Children's Hospital

Summary

Stollery Children's Hospital is a medical facility located in EDMONTON, Alberta. This center is recognized for care of Congenital Heart Diseases, Genetic Disorders, Migraine, Brain Tumor, Congenital Heart Defects and other specialties. Stollery Children's Hospital is involved with conducting 96 clinical trials across 248 conditions. There are 12 research doctors associated with this hospital, such as Sarah J. McKillop, Hien Huynh, Andrew Dixon, MD, and Sunil Desai, M.B.Ch.B., FRCP(c).

Top PIs

Clinical Trials running at Stollery Children's Hospital

Brain Tumor

Hemophilia B

Heart Failure

Inflammatory Bowel Disease

Crohn's Disease

Solid Tumors

Ulcerative Colitis

Colitis

Hemophilia

Hemophilia A

DAY101 vs. Chemotherapy

for Pediatric Brain Cancer

This trial is testing tovorafenib, a medication given alone, in children with a specific type of brain tumor. The drug works by blocking a protein that helps cancer cells grow.

Recruiting

2 awards

Phase 3

Repotrectinib

for Solid Tumors in Young Patients

Phase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies harboring anaplastic lymphoma kinase (ALK), receptor tyrosine kinase encoded by the gene ROS1 (ROS1), or neurotrophic receptor kinase genes encoding TRK kinase family (NTRK1-3) alterations to estimate the Maximum Tolerated Dose (MTD) or Maximum Administered Dose (MAD) and select the Pediatric Recommended Phase 2 Dose (RP2D). Phase 2 will determine the anti-tumor activity of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies harboring ROS1 or NTRK1-3 alterations.

Recruiting

1 award

Phase 1 & 2

14 criteria